Company / Total Assets
Kiniksa Pharmaceuticals International, plc Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$763.6M
FY2025
5-year range
$232.8M / $763.6M
FY2021-FY2025
Trend
+31.5%
vs FY2024
Sector context
#100 of 214
Health Care
What the data says
At $764M, Kiniksa Pharmaceuticals International, plc's total assets ranks #100 of 214 in the Health Care sector. Total Assets has increased for 4 consecutive years, from $233M in FY2021 to $764M in FY2025.
Based on SEC 10-K filings.
$764M in FY2025 with a 5-year CAGR of +16.9%.
Improved from $526M to $764M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +18.4%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
#100 of 214 in Health CareTop 47% of 214This company $763.6M Sector average $7.5B
▼
-89.8% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's total assets has grown for 4 consecutive years.
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2025, total assets increased 31.5% year-over-year.
- Ranks #100 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $763.6M | +31.5% |
| FY2024 | $580.6M | +10.3% |
| FY2023 | $526.3M | +14.5% |
| FY2022 | $459.7M | +97.5% |
| FY2021 | $232.8M | -33.4% |
| FY2020 | $349.5M | +37.3% |
| FY2019 | $254.5M | -20.9% |
| FY2018 | $322.0M | +577.9% |
| FY2017 | $47.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026